In vitro and in vivo Evaluation of Triptolide-loaded Pluronic P105 Polymeric Micelles

H. Li; X.-S. Wen; W. Di

doi:10.1055/s-0032-1312602

Arzneimittelforschung, Table of Contents

Arzneimittelforschung 2012; 62(07): 340-344
DOI: 10.1055/s-0032-1312602

Original Article

In vitro and in vivo Evaluation of Triptolide-loaded Pluronic P105 Polymeric Micelles

Authors

H. Li

¹Department of Chinese Traditional Medicine, Renji Hospital Jiaotong University School of Medicine, Shanghai, China
X.-S. Wen

¹Department of Chinese Traditional Medicine, Renji Hospital Jiaotong University School of Medicine, Shanghai, China
W. Di

¹Department of Chinese Traditional Medicine, Renji Hospital Jiaotong University School of Medicine, Shanghai, China

Abstract

Thin film method was applied successfully to prepare Triptolide (TP)-loaded micelles system. With a dynamic light scattering sizer and a transmission electron microscopy, it was shown that the TP-loaded micelles had a mean size of 84.3±6.4 nm with a spherical shape. The in vitro release profiles indicated that the release of TP from the micelles exhibited a sustained release behavior. A similar phenomenon was also observed in a pharmacokinetic study in rats, in which AUC of the micelles formulation were 4.7-fold higher than that of TP injection. The biodistribution study in rats showed that the TP-loaded micelles not only decreased drug uptake by liver, but also increased distribution of drug in ovary. The present work demonstrated the feasibility of controlled delivery of TP utilizing micelles system.

Key words

TP-loaded micelles - in vitro release - pharmacokinetic study - biodistribution study

Full Text

References

References
1 Barnes MN, Grizzle WE, Grubbs CJ et al. Paradigms for primary prevention of ovarian carcinoma. CA Cancer J Clin 2002; 52: 216-225
2 Rouzier R, Extra JM, Carton M et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breastconserving surgery. J Clin Oncol 2001; 19: 3828-3835
3 Yokoyama Y, Moriya T, Takano T et al. Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer 2006; 94: 1586-1591
4 Su D, Song Y, Li R. Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii. Zhong Xi Yi Jie He Za Zhi 1990; 10: 144-146
5 Yang SX, Gao HL, Xie SS et al. Immunosuppression of triptolide and its effect on skin allograft survival. Int J Immunopharmacol 1992; 14: 963-969
6 Hachida HLM, Enosawa S, Suzuki XKLS et al. Immunosuppressive effect of triptolide in vitro. Transplant P 1999; 3: 2056-2057
7 Zhang TM, Chen ZY, Lin C. Antineoplastic action of triptolide and its effect on the immunologic functions in mice. Acta Pharmacol Sin 1981; 2: 128-131
8 Zhang LX, Pan DJ, Zhang WJ et al. Inhibitory effect of tripterine on lymphocyte proliferation in mice. Acta Pharmacol Sin 1986; 7: 85-88
9 Qian SZ, Xu Y, Zhang JW. Recent progress in research on Tripterygium: a male antifertility plant. Contraception 1995; 5: 121-129
10 Hikim APS, Lue YH, Wang C et al. Post-testicular antifertility action of triptolide in the male rat: evidence for severe impairment of caude epididymal sperm ultrastructure. J Androl 2000; 21: 431-437
11 He MF, Huang YH, Wu LW et al. Triptolide functions as a potent angiogenesis inhibitor. Int J Cancer 2010; 126: 266-278
12 Zhu W, Ou Y, Li Y et al. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol 2009; 75: 812-819
13 Yang S, Chen J, Guo Z et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003; 2: 65-72
14 Shi X, Jin Y, Cheng C et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res 2009; 15: 1686-1697
15 Tengchaisri T, Chawengkirttikul R, Rachaphaew N et al. Sirisinha. Anti-tumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett 1998; 133: 169-175
16 Chan EW, Cheng SC, Sin FW et al. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol Lett 2001; 122: 81-87
17 Kiviharju TM, Lecane PS, Sellers RG et al. Antiproliferative and proapoptotic activities of triptolide (PG490), A natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 2002; 8: 2666-2674
18 Yang SM, Chen JG, Guo Z et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003; 2: 65-72
19 Zhou GX, Ding XL, Huang JF et al. Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines. Biochem Biophys Acta 2007; 1770: 1021-1027
20 Westfall SD, Nilsson EE, Skinner MK. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy 2008; 54: 67-76
21 Yu HY, Qin WZ. Selectness of active compounds in Tripterygium wilfordii and study on its toxicity. J Zhejiang Coll TCM 2000; 24: 70-71
22 Xiong FL, Chen HB, Chang XL et al. Research progress of triptolide-loaded nanoparticles delivery systems. Conf Proc IEEE Eng Med Biol Soc 2005; 5: 4966-4969
23 Zheng Q, Gong T, Sun X et al. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Arch Pharm Res 2006; 29: 1164-1170
24 Lin WJ, Chen YC, Lin CC et al. Characterization of pegylated copolymeric micelles and in vivo pharmacokinetics and biodistribution studies. J Biomed Mater Res B Appl Biomater 2006; 77: 188-194
25 Kabanov AV, Alakhov VY. Pluronic (R) block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst 2002; 19: 1-72